Reprogramming of mesenchymal stem cells by the synovial sarcoma-associated oncogene SYT-SSX2

Oncogene

Volumn 31, Issue 18, 2012, Pages 2323-2334

  Garcia, C B ^a   Shaffer, C M ^b   Alfaro, M P ^a   Smith, A L ^a   Sun, J ^a   Zhao, Z ^a   Young, P P ^a,c   Vansaun, M N ^a   Eid, J E ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

cancer; differentiation; gene expression

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR; PROTEIN; PROTEIN SYT SSX2; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL LINEAGE; CHROMOSOME TRANSLOCATION 18; CHROMOSOME TRANSLOCATION X; CONTROLLED STUDY; GENE CONTROL; MESENCHYMAL STEM CELL; MYOBLAST; NUCLEAR REPROGRAMMING; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SYNOVIAL SARCOMA;

CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; CELL TRANSFORMATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MESENCHYMAL STEM CELLS; MYOBLASTS; NEURONS; ONCOGENE PROTEINS, FUSION; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; SARCOMA, SYNOVIAL;

EID: 84861414679     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.418     Document Type: Article

References (42)

1. Alfaro MP, Pagni M, Vincent A, Atkinson J, Hill MF, Cates J ,et al. (2008). The Wnt modulator sFRP2 enhances mesenchymal stem cell engraftment, granulation tissue formation and myocardial repair. Proc Natl Acad Sci USA 105: 18366-18371.
2. Asp P, Blum R, Vethantham V, Parisi F, Micsinai M, Cheng J ,et al. (2011). Genome-wide remodeling of the epigenetic landscape during myogenic differentiation. Proc Natl Acad Sci USA 108: E149-E158.
3. Barco R, Hunt LB, Frump AL, Garcia CB, Benesh A, Caldwell RL ,et al. (2007). The synovial sarcoma SYT-SSX2 oncogene remodels the cytoskeleton through activation of the ephrin pathway. Mol Biol Cell 18: 4003-4012. (Pubitemid 47519491)
4. Barco R, Garcia CB, Eid JE. (2009). The synovial sarcoma-associated SYT-SSX2 oncogene antagonizes the polycomb complex protein Bmi1. PLoS One 4: e5060.
5. Chadashvili T, Peterson DA. (2006). Cytoarchitecture of fibroblast growth factor receptor 2 (FGFR-2) immunoreactivity in astrocytes of neurogenic and non-neurogenic regions of the young adult and aged rat brain. J Comp Neurol 498: 1-15. (Pubitemid 44198730)
6. Charytonowicz E, Cordon-Cardo C, Matushansky I, Ziman M. (2009). Alveolar rhabdomyosarcoma: is the cell of origin a mesenchymal stem cell? Cancer Lett 279: 126-136.
7. Colter DC, Sekiya I, Prockop DJ. (2001). Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci USA 98: 7841-7845. (Pubitemid 32642648)
8. Edgar R, Domrachev M, Lash AE. (2002). Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210. (Pubitemid 34679544)
9. Ever L, Gaiano N. (2005). Radial 'glial' progenitors: neurogenesis and signaling. Curr Opin Neurobiol 15: 29-33.
10. Farnham PJ. (2009). Insights from genomic profiling of transcription factors. Nat Rev Genet 10: 605-616.
11. Gurdon JB, Melton DA. (2008). Nuclear reprogramming in cells. Science 322: 1811-1815.
12. Haldar M, Hancock JD, Coffin CM, Lessnick SL, Capecchi MR. (2007). A conditional mouse model of synovial sarcoma: insights into a myogenic origin. Cancer Cell 11: 375-388. (Pubitemid 46518310)
13. Haldar M, Hedberg ML, Hockin MF, Capecchi MR. (2009). A CreER-based random induction strategy for modeling translocation-associated sarcomas in mice. Cancer Res 69: 3657-3664.
14. Huang W, Yang S, Shao J, Li YP. (2007). Signaling and transcriptional regulation in osteoblast commitment and differentiation. Front Biosci 12: 3068-3092.
15. Ishibe T, Nakayama T, Aoyama T, Nakamura T, Toguchida J. (2008). Neuronal differentiation of synovial sarcoma and its therapeutic application. Clin Orthop Relat Res 466: 2147-2155.
16. Ishibe T, Nakayama T, Okamoto T, Aoyama T, Nishijo K, Shibata KR ,et al. (2005). Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy. Clin Cancer Res 11: 2702-2712. (Pubitemid 40569472)
17. Katoh M. (2008). Cancer genomics and genetics of FGFR2. Int J Oncol 33: 233-237.
18. Katoh Y, Katoh M. (2009). FGFR2-related pathogenesis and FGFR2-targeted therapeutics. Int J Mol Med 23: 307-311.
19. Kawai A, Naito N, Yoshida A, Morimoto Y, Ouchida M, Shimizu K ,et al. (2004). Establishment and characterization of a biphasic synovial sarcoma cell line, SYO-1. Cancer Lett 204: 105-113. (Pubitemid 38117199)
20. Khan J, Bittner ML, Saal LH, Teichmann U, Azorsa DO, Gooden GC ,et al. (1999). cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. Proc Natl Acad Sci USA 96: 13264-13269.
21. Ladanyi M. (2001). Fusions of the SYT and SSX genes in synovial sarcoma. Oncogene 20: 5755-5762. (Pubitemid 32928113)
22. Lobo NA, Shimono Y, Qian D, Clarke MF. (2007). The biology of cancer stem cells. Annu Rev Cell Dev Biol 23: 675-699.
23. Lubieniecka JM, de Bruijn DR, Su L, van Dijk AHA, Subramanian S, van de Rijn M ,et al. (2008). Histone deacetylase inhibitors reverse SS18-SSX2-mediated polycomb silencing of the tumor suppressor early growth response 1 in synovial sarcoma. Cancer Res 68: 4303-4310.
24. Mackall CL, Meltzer PS, Helman LJ. (2004). Focus on sarcomas. Cancer Cell 2: 175-178. (Pubitemid 41043972)
25. Maric D, Fiorio Pla A, Chang YH, Barker JL. (2007). Self-renewing and differentiating properties of cortical neural stem cells are selectively regulated by basic fibroblast growth factor (FGF) signaling via specific FGF receptors. J Neurosci 27: 1836-1852.
26. Martens JA, Winston F. (2003). Current advances in understanding chromatin remodeling by Swi/Snf complexes. Curr Opin Genet Dev 13: 136-142. (Pubitemid 36369737)
27. Mateos-Langerak J, Cavalli G. (2008). Polycomb group proteins and long-range gene regulation. Adv Genet 61: 45-66.
28. Miraoui H, Marie PJ. (2010). Fibroblast growth factor receptor signaling crosstalk in skeletogenesis. Sci Signal 3: re9.
29. Muruganandan S, Roman AA, Sinal CJ. (2009). Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: crosstalk with the osteoblastogenic program. Cell Mol Life Sci 66: 236-253.
30. Nagai M, Tanaka S, Tsuda M, Endo S, Kato H, Sonobe H ,et al. (2001). Analysis of transforming activity of human synovial sarcoma-associated chimeric protein SYT-SSX1 bound to chromatin remodeling factor hBRM/hSNF2a. Proc Natl Acad Sci USA 98: 3843-3848. (Pubitemid 32249859)
31. Naka N, Takenaka S, Araki N, Miwa T, Nobuyuki H, Yoshioka K ,et al. (2010). Synovial sarcoma is a stem cell malignancy. Stem Cells 28: 1119-1131.
32. Nielsen TO, West RB, Linn SC, Alter O, Knowling MA, O'Connell JX ,et al. (2002). Molecular characterisation of soft tissue tumours: a gene expression study. Lancet 359: 1301-1307. (Pubitemid 34310636)
33. Odelberg SJ, Kohlhoff A, Keating MT. (2000). Dedifferentiation of mammalian myotubes induced by msx1. Cell 103: 1099-1109. (Pubitemid 32037396)
34. Pardo OE, Latigo J, Jeffery RE, Nye E, Poulsom R, Spencer-Dene B ,et al. (2009). The fibroblast growth factor receptor inhibitor PD173074 blocks small cell lung cancer growth in vitro and in vivo. Cancer Res 69: 8645-8651.
35. Pretto D, Barco R, Rivera J, Neel N, Gustavson MD, Eid JE. (2006). The synovial sarcoma translocation protein SYT-SSX2 recruits bcatenin to the nucleus and associates with it in an active complex. Oncogene 25: 3661-3669. (Pubitemid 43980487)
36. Pruitt KD, Tatusova T, Maglott DR. (2007). NCBI Reference Sequence (RefSeq): a curated non-redundant database of genomes, transcripts and proteins. Nucleic Acids Res 35(Database issue): D61-D65. (Pubitemid 46056171)
37. Schuettengruber B, Chourrout D, Vervoort M, Leblanc B, Cavalli G. (2007). Genome regulation by polycomb and trithorax proteins. Cell 128: 735-745. (Pubitemid 46273581)
38. Sekiya I, Larson BL, Smith JR, Pochampally R, Cui JG, Prockop DJ. (2002). Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 20: 530-541. (Pubitemid 35463066)
39. Villegas SN, Canham M, Brickman JM. (2010). FGF signaling as a mediator of lineage transitions-evidence from embryonic stem cell differentiation. J Cell Biochem 110: 10-20.
40. Watanabe Y, Kameoka S, Gopalakrishnan V, Aldape KD, Pan ZZ, Lang FP ,et al. (2004). Conversion of myoblasts to physiologically active neuronal phenotype. Genes Dev 18: 889-900. (Pubitemid 38529658)
41. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE ,et al. (2008). Model-based analysis of ChIP-Seq (MACS). Genome Biol 9: R137.
42. Zhao C, Deng W, Gage FH. (2008). Mechanisms and functional implications of adult neurogenesis. Cell 132: 645-660. (Pubitemid 351253687)